Pakistan’s Pharma Sector Surges with Record-Breaking Exports

Pakistan’s Pharma Sector Surges with Record-Breaking Exports

Pakistan’s pharmaceutical industry has reached a historic milestone, recording its highest export figures in two decades. According to recent data, pharma exports soared to $457 million in the last fiscal year, marking a 34% increase compared to the previous year.

This remarkable growth is largely attributed to the government’s pro-industry reforms, particularly the deregulation policy introduced in 2023. The policy helped resolve medicine shortages and restored confidence among manufacturers, enabling them to expand production and tap into international markets.

Tariq H. Taqi, Chairman of the Pharmaceutical Manufacturers Association, praised the policy shift, calling it a “fresh breeze” for the industry. He emphasized that with continued support and consistent regulation, Pakistan’s pharma exports could potentially reach $3–4 billion in the coming years.

The export surge reflects a broader transformation in Pakistan’s economic strategy, one that prioritizes industrial growth and global competitiveness. The pharmaceutical sector, once constrained by regulatory hurdles, is now emerging as a key contributor to national exports.

Industry leaders believe that Pakistan’s pharma market holds immense potential, especially with rising demand for affordable and quality medicines across developing regions. With the right incentives and infrastructure, the country could become a major player in global pharmaceutical trade.

This record-breaking performance not only highlights the resilience of Pakistan’s pharma sector but also signals a promising future for industrial innovation and export-led growth.